Sort
21,281 grants matching “influenza”
Project 2: mRNA vaccine development against Bunyaviruses, Paramyxoviruses and Picornaviruses
$3,953,703Norbert Pardi · University Of California-Irvine · U19 · FY2024 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,952,213Walter A. Orens · Emory University · N01 · FY2015 · AI
REDUCING THE THREAT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS AND AVIAN INFLUENZA IN JORDAN&STRENGTHENING REGIONAL DISEASE SURVEILLANCE CAPACITY
$3,924,953Ecohealth Alliance Inc · · FY2025 · Defense Threat Reduction Agency
ADDRESSING EMERGING INFECTIOUS DISEASES IN BANGLADESH
$3,919,682Sara Latrielle · International Ctr/Diarrhoeal Dis Res · U01 · FY2013 · CI
Research on the Epidemiology,Prevention,Vaccine Effectiveness and Treatment of Influenza and Other Respiratory Viruses in South Africa.09
$3,908,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2016 · IP
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$3,883,567Mark M Davis · Stanford University · U19 · FY2014 · AI
SEA Influenza Clinical Research Network
$3,882,006 · N01 · FY2007 · CA
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$3,874,619Mark M Davis · Stanford University · U19 · FY2020 · AI
ATCC's High Containment Facility Renovations in Support of NIAID and Pandemic Preparedness
$3,862,721Rebecca Bradford · American Type Culture Collection · G20 · FY2022 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$3,849,776Daniel F. Hoft · Saint Louis University · UM1 · FY2021 · AI
Targeting Viroporins and Coronavirus M Protein
$3,846,686William F Degrado · University Of California, San Francisco · U19 · FY2022 · AI
Center for Human Immunology
$3,831,897Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Influenza Vaccine Development
$3,806,087Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
STATISTICAL AND DATA COORDINATING CENTER FOR CLINICAL RESEARCH ON INFLUENZA
$3,803,094Marian Ewell · The Emmes Company, Llc · N01 · FY2018 · AI
Advanced Development of Vaccines for Infectious Diseases
$3,802,919Ly Phan · Versatope Therapeutics, Inc. · N01 · FY2020 · AI
ARRA ^ H1N1 Influenza Comparative Pathogenesis
$3,787,927Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
ARRA ^H1N1 Influenza Clinical Research
$3,787,927Jeffery Taubenberger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Center for Human Immunology
$3,754,469John Tsang · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
Novel TLR7/8 agonists as adjuvants for rapid-acting vaccines
$3,750,387David Johnson · Corixa Corporation · N01 · FY2013 · AI
Administrative Core
$3,740,347Marcella Nunez-Smith · Yale University · U54 · FY2020 · MD
Community-Engaged Research on COVID-19 Testing in the US Territories
$3,740,347Cruz M Nazario · Yale University · U54 · FY2020 · MD
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE: AVIAN INFLUENZA RESEARCH
$3,737,929Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2025 · AI
NIAID CENTERS OF EXCELLENCE FOR INFLUENZA AND SURVEILLANCE
$3,735,044John Jay Treanor · University Of Rochester · N01 · FY2010 · AI
ADDRESSING EMERGING INFECTIONS DISEASE IN BANGLADESH
$3,729,101Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2017 · GH
Influenza and Emerging Infectious Diseases
$3,718,933Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI